Citation Impact
Citing Papers
Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes
2020 StandoutNobel
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
2016 StandoutScience
Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage
2016 StandoutScienceNobel
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Machine learning predicts new anti-CRISPR proteins
2020 StandoutNobel
AID−/−μs−/− Mice Are Agammaglobulinemic and Fail to Maintain B220−CD138+ Plasma Cells
2007 StandoutNobel
Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR–Cas system
2016
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Linking CRISPR-Cas9 interference in cassava to the evolution of editing-resistant geminiviruses
2019
The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation
2016
Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape
2017
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
2015 Standout
Activation of Autoreactive B Cells by CpG dsDNA
2003
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Class Switch Recombination and Somatic Hypermutation in Early Mouse B Cells Are Mediated by B Cell and Toll-like Receptors
2007 StandoutNobel
Expanding the Biologist’s Toolkit with CRISPR-Cas9
2015 StandoutNobel
Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems
2016
Toll-like receptor control of the adaptive immune responses
2004 Standout
New CRISPR–Cas systems from uncultivated microbes
2016 StandoutNatureNobel
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Pattern Recognition Receptors and Inflammation
2010 Standout
Harnessing Type I and Type III CRISPR-Cas systems for genome editing
2015
Controlling and enhancing CRISPR systems
2020 StandoutNobel
Exploiting CRISPR–Cas immune systems for genome editing in bacteria
2015
A decade of discovery: CRISPR functions and applications
2017
Enhanced proofreading governs CRISPR–Cas9 targeting accuracy
2017 StandoutNatureNobel
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
2016 StandoutNatureNobel
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
CRISPR-Cas immunity in prokaryotes
2015 Nature
Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers
2022
Cas9 specifies functional viral targets during CRISPR–Cas adaptation
2015 Nature
A Broad-Spectrum Inhibitor of CRISPR-Cas9
2017 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Extrafollicular antibody responses
2003
Antibiotic-Induced Changes in the Intestinal Microbiota and Disease
2016
The CRISPR-Cas immune system: Biology, mechanisms and applications
2015
Bacterial CRISPR: accomplishments and prospects
2015
Conformational control of DNA target cleavage by CRISPR–Cas9
2015 StandoutNatureNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity
2017 Nature
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
2016 StandoutNobel
T Cell-Independent and Toll-like Receptor-Dependent Antigen-Driven Activation of Autoreactive B Cells
2008
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
2006 StandoutNature
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation
2020 StandoutNobel
Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit
2016
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
2005
The Biology of CRISPR-Cas: Backward and Forward
2018 StandoutNobel
Characterization and Repurposing of Type I and Type II CRISPR–Cas Systems in Bacteria
2018
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
CasX enzymes comprise a distinct family of RNA-guided genome editors
2019 StandoutNatureNobel
Harnessing CRISPR–Cas systems for bacterial genome editing
2015
Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response
2016 StandoutNobel
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Presence of somatic hypermutation and activation‐induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21)
2004
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Chronic Lymphocytic Leukemia
2005
Genome-editing Technologies for Gene and Cell Therapy
2016
Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
2015
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
2016 Science
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
In Vivo Regulation of Bcl6 and T Follicular Helper Cell Development
2010
CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems
2015
Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease
2007
Systematic discovery of natural CRISPR-Cas12a inhibitors
2018 StandoutScienceNobel
MARGINAL ZONE B CELLS
2004
Evolution and Ecology of CRISPR
2016
CRISPR-Cas: biology, mechanisms and relevance
2016 StandoutNobel
CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis
2016
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
2020 StandoutNobel
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
Engineering of temperature- and light-switchable Cas9 variants
2013 StandoutNobel
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria
2015
Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems
2016
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
CRISPR‐Based Technologies and the Future of Food Science
2015
Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells
2006
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Chad W. Euler being referenced
Evolution of Autoantibody Responses via Somatic Hypermutation Outside of Germinal Centers
2002 Science
Short-Lived Plasmablasts Dominate the Early Spontaneous Rheumatoid Factor Response: Differentiation Pathways, Hypermutating Cell Types, and Affinity Maturation Outside the Germinal Center
2005
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
2014
A natural single-guide RNA repurposes Cas9 to autoregulate CRISPR-Cas expression
2021
B Cell Tolerance Checkpoints That Restrict Pathways of Antigen-Driven Differentiation
2006
Visualizing the Onset and Evolution of an Autoantibody Response in Systemic Autoimmunity
2005